Rare
lephants
Screener
Toggle theme
C
C21 Investments Inc.
CWLXF
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Sales Per Share
Compare
←
5Y
10Y
MAX
→
Sales Per Share
Chart
Table
Fiscal Year
Sales Per Share
FY2022
$0.27
FY2023
$0.24
FY2024
$0.23
FY2025
$0.25
FY2026
$0.28
Download CSV